Embra

The market's appetite for AI applications in healthcare is rapidly increasing, with TEM emerging as a top contender in this high-growth sector.

Ambarella (NASDAQ: AMBA) stock has been in red-hot form on the market since the second half of 2024, but its healthy rally came to an abrupt halt following the release of its fiscal 2025 fourth-quarter results (for the three months ended Jan.

As AI-powered devices become more ubiquitous, Wearable Devices is actively developing next-generation intuitive and personalized user interactions. With over a decade of research and development and a growing portfolio of patents, the Company invites industry leaders to explore collaboration opportunities.

When I saw that Headspace had added Ebb, an AI-powered companion, to its membership, I was intrigued. Ebb was built to provide personalized support through a chatbot. You can use Ebb to process thoughts and emotions or find gratitude, as a complement to the meditation and mindfulness content Headspace has been known for since 2012.

Coming into its acquisition, Edge had raised $8.25 million in funding over five rounds. Investors in the company included Ventureeast Fund Advisors Pte. Ltd., Kalaari Capital Advisors Pte. Ltd., Exfinity Venture Partners LLP, Launchpad Accelerator, Caspian Impact Investment Adviser Pte. Ltd. and L.J. International Inc.

Backed by Eros Innovation, Immerso brings unparalleled resources to the table. Eros Media World boasts a 30% market share in the Indian film industry, selling 2.7 billion tickets annually and reaching a global audience in the billions. This partnership unlocks the potential to become the world's largest film market for metaverse engagement.

With customer experience (CX) at the forefront of business minds, this advancement has sparked the attention of industry leaders, innovators and strategists alike. As the demand for lightning-fast, personalized experiences grows more prominent, a key question arises: can businesses rely on emotionally attuned AI to deliver?

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an expanded partnership with Softek Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients from electronic medical records (EMR),